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Summary.-Mouse tumour cells were treated with various chemical modifiers.
The number of modifying groups per cell was determined with labelled reagents.
The effects of the different modifying groups on the immunogenicity of the tumour
cells was tested in syngeneic mice for tumour protection using a challenge dose
of viable cells at 1000 or 10,000 times LD100. Best protection was obtained after
immunization of animals with tumour cells modified with dimethylsulphate or
acetic anhydride, or with glutardialdehyde-fixed cells treated with a carbodiimide
and methylamine. Up to 40% of the animals remained tumour-free. The other
animals exhibited a greatly increased mean survival time. The post-challenge
sera showed no detectable amounts of antibodies against the tumour cells.
INVESTIGATIONS directed towards de-
termining the influence of chemical modi-
fication onthe immunogenicity ofantigens
have been reported by several groups
(Parish, 1971; Coon and Hunter, 1972;
Thompson, Harries and Benjamini, 1972;
Staab and Anderer, 1976). In several
cases stimulation predominantly of the
cellular immune response could be achiev-
ed. In a recent review (Prager and
Baechtel, 1973) some attempts have been
recorded in which these immunological
stimulations were used for the control
of malignant neoplasms. Chemically
modified tumour cells or tumour cell
extracts were tested for their capacity to
induce protection against the challenge of
homologous native tumour cells. After
immunization with tumour cells modified
with N-ethylmaleimide or iodoacetate,
Prager et al. (1971) found that mice could
be protected against a subsequent chal-
lenge with viable tumour cells. The
observed protection was due to a cellular
immune response, since no humoral anti-
bodies against the tumour cells could
be detected in the immunized animals.
Other groups obtained some protection
by immunizing the animals with tumour
cells treated with acetic anhydride or
formaldehyde (Yoshimura and Kaburaki,
1963; Panteleakis et al., 1971; Lin, Huber
and Murphy, 1969). The degree of pro-
tection ranged from very high to hardly
any protection. A conclusive comparison
cannot be made, as the investigators
used different cell lines in their experi-
ments. The malignancy of the different
cell lines varied greatly, the LD1oo
ranging from 102 to 106 tumour cells per
animal. In addition, the conditions for
the chemical modifications differed as well
as the immunization schedules.
The aim of the present study was
to survey the influence of various modi-
fying chemicals on the immunogenic
capacity of a mouse sarcoma tumour
cell line. During the whole period of
the study the tumour cells of5 consecutive
passages were used, exhibiting an LD100
of 102 cells per animal. The tumour
cells were syngeneic with the experimental
animals. All chemical modifications of
the tumour cells were performed under
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conditions leaving most of the cells
morphologically intact. The numbers of
modifying groups bound to a cell were
determined in separate experiments using
radioactive reagents. In all experiments
a challenge of 105 or 106 tumour cells,
corresponding to 1000 and 10,000 times
LD100 were used. Attempts were made
to characterize the type of immune
response after challenge, using sero-
logical methods.
MATERIALS AND METHODS
Cells.-The cell line STU-D17 used
throughout was obtained from STU mouse
embryo cells transformed by Rous sarcoma
virus (Schmidt-Ruppin strain). The cell
line was kindly supplied by Dr Heinz Bauer,
University of Giessen, Germany.
Radiochemicals.-[L14C]-acetic anhydride,
[14C]-methylamine, [14C]-dimethylsulphate,
and N-[14C]-ethylmaleimide were purchased
from the Radiochemical Centre, Amersham,
England, and [14C]-formaldehyde from NEN,
Boston, USA.
Chemicals. -1-Ethyl-3(3-dimethylamino-
prop3l)-carbodiimide (EDC) was obtained
from the Ott Chemical Co., Muskegon,
Mich., USA. All other chemicals were of
analytical grade, and were obtained from
Merck, Darmstadt, Germany.
Preparation of the cells.-The cells were
grown in minimum essential medium supple-
mented with 10% of foetal calf serum
(Dulbecco and Freemann, 1959). The cells
were harvested by treatment with trypsin,
washed x 3 in ice-cold phosphate-buffered
saline (PBS), and resuspended in PBS to give
a standard concentration of5 x 106 cells/ml.
Conditions ofcell modification.-Generally,
10-ml portions of STU-D17 cells of standard
concentration were reacted with the chemical
reagents. In Table I the reaction conditions
are listed of those modifying reagents which
induced a significant immunogenic effect.
In the case of modification with glutardi-
aldehyde + butylamine both chemicals were
added together. In the case of glutardi-
aldehyde + EDC/methylamine the cells were
washed after glutardialdehyde fixation, in-
cubated in PBS for 18 h, followed by simul-
taneous addition of EDC and methylamine.
Modification of cells was also performed
with N-ethylmaleimide (50 mM), glutardial-
dehyde + methylamine (200 + 600 mM), glu-
tardialdehyde + dimethylsulphate (200 + 50
mM), EDC + methylamine (2 + 150 mM) as
well as by treatment with sodium peroxide
(1 mM) followed by acetoacetylation with
diketene (50 mM). Termination of the reac-
tions was achieved by washing the modified
cell samples 3 x with cold PBS. The
modified cells were injected into the animals
without delay.
For the determination of the number
of modifying groups per cell, 5-ml portions
of STU-D17 cells were reacted with 14C-
labelled chemicals.
Immunization procedures.-Highly inbred
STU mice (Committee on Standardized
Nomenclature for inbred strains of mice,
1968) 4-6 weeks old were used in all experi-
ments. Groups of 10 animals were im-
munized, each with a single s.c. injection
(0.2 ml) into the left flank, with doses
varying between 102 and 106 of modified
cells. Fourteen days after immunization,
the mice received a challenge of 105 or 106
viable STU-D17 tumour cells (0-2 ml) s.c.
into the neck. Controls were 20 animals
TABLE I. Reaction of STU-D17 Mouse Tumour Cells (5 x 106 cells/ml) with Various
Reagents in PBS pH 7*3
Concentration Reaction time Reaction temnerature Reagent (mM) (min) - C) 00 Ce-
Dimethylsulphatea 50 10 37
Acetic anhydride 50 10 4
Diketene 50 10 37
Formaldehyde 200 180b 37
Glutardialdehyde 200 180b 37
Glutardialdehyde 200 180b 37 c +butylamine + 600
Glutardialdehyde 200 180b 37 (
+ (EDC+methylamine) + (2+ 150) +180
a Cells were suspended in PBS pH 7-3 containing 5 O glycerol and 5% ethanol.
b After washing, the cells were further incubated in PBS pH 7 3 at room temperatture for 18 h.
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per group receiving only a challenge of
viable tumour cells. When groups of mice
were immunized with X-irradiated tumour
cells, the cell samples were washed x 3
with cold PBS after exposure to 5000-6000
rad.
To study the influence of the interval
between immunization and challenge, 3
groups of mice which had been immunized
with tumour cells modified with formaldehyde
received the challenge 42 days after im-
munization.
The effect of multiple immunization
was studied with tumour cells modified
with glutardialdehyde. The animals re-
ceived 3 immunizations at weekly intervals,
followed by challenge 2 weeks after the last
immunization.
All samples of modified cells were tested
for viability using groups of 10 mice. Each
animal received an injection of 106 modified
cells in 0-2 ml PBS, and the appearance
of tumours was observed over a period of
110 days.
Serology. For comparative serological
studies, the mice were bled 7 days after
tumour challenge by puncturing the retro-
orbital sinus. The individual sera of each
group were pooled. Serum dilutions 1: 20
were tested in a microcytotoxicity assay
(Baldwin and Embleton, 1971) for cytotoxic
antibodies directed against native STU-D17
cells. In addition, the sera were assayed in
an indirect membrane fluorescence test
(Beutner, Holborow and Johnson, 1967)
using FITC-labelled rabbit anti-STU-im-
munoglobulin sera.
RESULTS
One of the factors influencing the
immunogenicity of an antigen has been
shown to be the number of modifying
groups per antigen molecule (Parish, 1971;
Staab and Anderer, 1976). The immuno-
genic capacity to induce specific cellular
immune responses increased with increas-
ing numbers of modifying groups, but
optimal effects were achieved before all
the reactive sites of the antigen had
reacted (Parish, 1971).
For all types of chemical modification
performed with STU-D17 tumour cells,
saturation curves have been established
using 14C-labelled reagents. In the range
of saturation of some reactions, a con-
siderable portion of the cells was destroy-
ed, most probably as a result of intensive
chemical modification. Therefore the
concentration of the reagents was reduced
to give at most 3000 loss of cells (see
Table I). The ratio of modifying groups
per cell could be calculated on the basis
of the specific radioactivity of the re-
agents, the labelling of the cells and the
cell number. The data are listed in
Table II. In the case of the reactions
TABLE 1I.-Ratios of Modifying Groups
per Cell Given for Various Modification
Reactions at Saturation and Standard
Reaction Conditions
Modifying reagent
[14C]-dimethylsulphate
[14C]-acetic anhydride
[14C]-formaldehyde
Glutardialdehyde
+[14C]-methylamine
EDC+ [14C]-methylamine
N-['4C]-ethylmaleimide
Modifying groups/cell
Saturation Standard
conditions conditions
1* 8 x 1010 6-8 x 109
4-2 x 1010 2*1 x1010
9*Ox 1010 6.9 x 1010
7l1 x 1010 6-2x 1010
80x 109 4-6x 109
1 2 x 1010 5-1 x 109
with diketene, glutardialdehyde and butyl-
amine, no radioactive label was used,
but one can assume comparable ratios
to those given for acetic anhydride,
formaldehyde and methylamine respect-
ively.
The STU-D17 tumour cells modified
according to the standard conditions were
routinely tested for viability in vitro by
trypan blue uptake and in vivo by a
single injection of 106 modified cells per
animal. No group of animals developed
tumours within 110 days, except the
group which received N-ethylmaleimide-
modified tumour cells, where 70% of
the animals showed tumour growth.
The latter finding is in agreement with
the results obtained with iodoacetate,
which is another sulphydryl reagent
(Jasmin, Piton and Rosenfeld, 1968). It
is noteworthy that trypan blue uptake
did not coincide with the loss of viability
of the cells. In some cases only 20%
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of the modified cells showed trypan blue
uptake, but no tumours developed when
the cells were injected into mice.
In the course of the immunization
experiment we determined the number
of animals which remained tumour-free
during 90 days after challenge with viable
cells. For those mice which developed
tumours, the mean survival time was
calculated as an additional criterion for
induced immunity against the tumour
transplant. In Table III the results of
the experiments with modified cells are
listed only for those which induced a
significant immune reaction against the
tumour challenge. The results of those
experiments obtained with mice immun-
ized with X-irradiated tumour cells are
also given.
When a challenge of 105 tumour cells
was given, in 2 c4ses up to 40% of the
animals showed full protection and re-
mained tumour-free, whereas the experi-
mental groups of mice immunized with
TABLE III.-Protection ofSTU Mice against Challenge with 105 or 106STU-D17 Tumour
Cells after Pretreatment with Various Dosages of Modified STU-D17 Tumour Cells.
The Challenge was given 14 Days after Immunization Unless Otherwise Stated
Type of modification
Controls
Dimethylsulphate
Acetic anhydride
Diketene
Formaldehyde
EDC+methylamine
Glutardialdehyde
Immunization
log cells
per animal
2
3
4
6
2
3
4
6
2
3
4
6
2
3
4
6
2
3
4
6
2
3
4
6
2c
4c
6c
2
3
4
6
2
3
4
6
2d
4d
6d
Challenge
log cells
5
6
5
5
5
5
6
6
6
6
5
5
5
5
5
5
5
5
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Tumour-free
animalsa
% per group
0
0
20
0
30
30
0
30
30
0
20
40
20
20
10
10
10
10
0
0
10
0
0
30
10
10
0
0
0
0
0
10
0
0
10
0
0
0
20
0
Mean survivalb
Days % of control
40
24
49
57
73
39
27
28
61
32
43
72
55
42
41
52
42
38
40
41
40
36
43
50
62
50
45
50
50
53
61
45
45
42
45
39
38
48
52
48
100
100
123
142
183
98
112
117
254
133
108
180
138
105
103
130
105
95
167
171
167
150
108
125
155
125
113
125
125
132
153
113
113
105
113
98
95
120
130
120
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TABLE III.-Continued.
Tvpe of modification
Glutardialdehyde
+butylamine
Glutardialdehyde
+ (EDC+methylamine)
X-irradiation
Immunization
log cells
per animal
2
3
4
6
2
3
4
6
2
3
4
6
2
3
4
6
2
3
4
6
Tumour-freea
Challenge animals
log cells % per group
5
5
5
5
5
5
5
5
6
6
6
6
5
5
5
6
6
6
6
6
30
0
20
10
40
30
30
0
0
0
20
20
20
20
0
0
0
0
0
0
Mean survivalb
D
Days °b Of control
46
42
47
51
67
56
51
28
28
22
22
25
50
59
58
57
27
23
26
27
115
105
118
128
168
140
128
70
117
92
92
104
125
148
145
142
112
96
108
112
a No palpable tumours 90 days after challenge.
b Tumour-bearing animals only.
c Challenge 42 days after immunization.
d 3 immunizations at weekly intervals.
X-irradiated tumour cells showed at most
up to 20% of tumour-free animals.
Most of the animals which developed
tumours showed highly increased mean
survival times. The maximum mean
survival times were usually found in
those groups which also had the highest
percentage of tumour-free animals. It
was found that these maxima were
essentially dependent on the number of
modified cells used for immunization.
As can be seen from Table III, the
best results were obtained with an im-
munizing dose of between 102 and 104
modified cells. Modification with di-
methylsulphate and acetic anhydride as
well as complex modification with glutar-
dialdehyde/(EDC + methylamine) induc-
ed an almost equal increase in the im-
munogenicity ofthe STU-D17 cells. These
reactions also showed the optimal effect
which had been found in the course
of our work. All the other modified
cell samples, including the X-irradiated
cells, proved to be less efficient in inducing
an immune response, but still showed
significant tumouir protection and in-
creased mean survival times.
Moreover, in the case ofimmunizations
with cell samples modified with dimethyl-
sulphate, diketene or glutardialdehyde/
(EDC + methylamine) and with X-irradi-
ated cells, the challenge dosage was raised
to 106 tumour cells. Tumour protection
and increased mean survival time induced
by dimethylsulphate-modified cells were
as efficient as with the challenge of 105
tumour cells. In the other cases a
significant but lower tumour protection
was observed (Table III).
In order to obtain some information
on the persistence of tumour protection,
in one experiment animals immunized
with formaldehyde-treated cells received
105 viable tumour cells 42 days instead
of 14 days after immunization. As can
be seen from Table III, no tumour-free
animals and only a moderate increase
in the mean survival time were observed.
The effect of multiple immunization
was studied with glutardialdehyde-treated
cells, which induced only weak immuno-
genicity after a single immunizing injec-
tion. In this experiment, 3 injections at
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weekly intervals were given, followed by
a challenge of 105 tumour cells 14 days
later. Only a slight increase in tumour
protection and in the mean survival time
were obtained.
The persistence of tumour immunity
after immunization and challenge was
studied with tumour-free animals which
had been immunized with glutardialde-
hyde/(EDC + methylamine) modified
cells. A second challenge of 105 tumour
cells was given 180 days after the first
challenge. Ninety days later 80% of
the animals were still tumour-free.
All the other groups immunized with
modified cell samples but not listed in
Table III had only up to 20% tumour-free
animals, and the mean survival times
were only slightly increased. As already
mentioned, cell samples modified with
N-ethylmaleimide still had the capacity
to induce tumours in 70% of the animals
when the immunizing dosage was 106
cells. The other 30% of the animals
remained tumour-free, but did not show
any tumour protection when a challenge
of 105 viable tumour cells was given.
When immunization was done with doses
of 103 or 104 modified cells, no tumour
growth was observed, but the mean
survival time after challenge with viable
tumour cells was distinctly less than that
of the control groups.
To characterize the type of immune
response induced by the modified cell
samples, the pooled sera obtained 7 days
after the tumour challenge were assessed
in the microcytotoxicity assay, and in
the indirect membrane immunofluores-
cence test. With the exception of the
animals which had been immunized with
cells modified with N-ethylmaleimide or
by treatment with Na202/diketene, no
antibodies (i.e. lessthan 50% cytotoxicity)
could be detected in the sera of all the
other groups with either method. The
detection of antibodies in the sera of
animals immunized with N-ethylmale-
imide-treated cells was dependent on
the immunizing dose. Antibodies were
present when the animals were immunized
with 103, 104 and 106 modified cells
(cytotoxicity: 96%, 93% and 94% re-
spectively). The dosage of 102 modified
cells did not induce detectable amounts
ofhumoral antibodies (50% cytotoxicity).
The same holds true for animals immuniz-
ed with Na2O2/diketene-treated cells. Cy-
totoxicity was 52%, 60% and 77% when
the immunizing dosage was 103, 104 or
106 modified cells. These findings cor-
relate with the partly decreased mean
survival times in these groups, indicating
that the antibodies might have exhibited
an enhancing effect on tumour growth.
DISCUSSION
For the interpretation of any effect
on the immunogenicity of tumour cells
which can be induced by chemically
distinct modifying groups, it is of great
importance that the antigenic patterns
of tumour cells and experimental animals
differ by nothing but tumour antigens.
To meet these requirements we chose a
syngeneic tumour cell line, thus excluding
any effects due to differences in histo-
compatibility antigens.
On the other hand we thought it
advantageous to work with modifying
groups which were known to have no
detectable haptenic character. With one
exception, all modifying reactions with
tumour cells as well as X-irradiation
were carried on to the extent that the
modified cells were no longer capable of
cell division. The effects on the immuno-
genicity of the tumour cells were charac-
terized by two parameters: tumour pro-
tection and mean survival time oftumour-
bearing animals. Tumour protection was
established against a tumour challenge
of 1000 or 10,000 times the LD100. Full
tumour protection exceeding 90 days
was thought to be sufficient, since this
period is analogous to more than 5 years
of human life.
Optimal tumour protection and in-
creased mean survival time were found
to be dependent on the modifying groups
and on the dose of modified cells used
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for immunization. Modification of tum-
our cells with dimethylsulphate or
acetic anhydride, or of glutardialdehyde-
fixed cells treated with carbodiimide and
methylamine, induced the most efficient
alteration of immunogenicity. Best re-
sults were found with the lower immuniz-
ing doses rather than with the high
dose of 106 modified cells. In some
experiments even 102 modified cells were
sufficient to induce a significant tumour
protection. This can be understood in
terms of a critical range of the amount
of antigen responsible for antigen recogni-
tion. Since in the experiments showing
optimal tumour protection no humoral
antibodies could be detected, one can
conclude that this critical range only
involves the cellular immune response.
It is noteworthy that several types
of chemical modification of the tumour
cells chosen for our study proved to be
more efficient in inducing tumour pro-
tection than X-irradiation. The radia-
tion-induced alterations of immunogeni-
city are compatible with the findings
of other authors who had investigated
leukaemic mouse cells (Lin, Huber and
Murphy, 1969).
In our study we selected modifying
groups which were aliphatic, of small
size and, when conjugated with proteins,
were known to induce cellular immunity
against protein antigens without inducing
humoral antibodies against the modifying
groups (Parish, 1971; Coon and Hunter,
1972; Thompson, Harries and Benjamini,
1972; Staab and Anderer, 1976; Bena-
cerraf and Gell, 1959). The number
of modifying groups per cell differed from
saturation by a factor of 2 at most, thus
following the findings obtained with pro-
tein antigens (Parish, 1971; Staab and
Anderer, 1976). Considering the mem-
brane structure and the type of chemical
reagents used, one has to assume that
the modifying groups had reacted with
sites not only on the cell surface but also
inside the cell. The chemical alterations
on the cell surface induced by the modi-
fying groups which led to an efficient
increase in the capacity to induce a
cellular immune response, can be generally
correlated with changes of the charge
pattern on the cell surface. All the
modifying reactions investigated resulted
in an overall reduction of charges. Di-
methylsulphate reacts with amino groups
without a change in the charge, and with
SH-groups and phenolic OH-groups, but
also with carboxylic groups (Staab and
Anderer, 1976) thus reducing the total
number of negative charges. The reac-
tion of EDC and methylamine also
diminishes the number ofnegative charges.
A reduction of positive charges results
from the reactions with acetic anhydride,
diketene and with aldehydes.
On the basis of our results one has to
question whether alterations ofthe surface
charge pattern (i.e. reduction of negative
and positive charges) do generally increase
the immunogenic capacity by promoting
a cellular immune response. It would be,
therefore, of great interest to investigate
the modification reactions which have
proved to be efficient in our study in
other syngeneic systems of tumour cells
and experimental animals.
The authors would like to thank
Ms U. Abrutsch for her excellent technical
assistance.
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